Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CAPITAL AND CODEINE

02 8CLOBAZAM

03 1E.E.S.

04 1E.E.S. 400

05 2EMFLAZA

06 1ERYPED

07 1FLOLIPID

08 1FURADANTIN

09 2GRISEOFULVIN

10 1LIKMEZ

11 1NAPROSYN

12 1NAPROXEN

13 1NITROFURANTOIN

14 3NYSTATIN

15 3PHENYTOIN

16 1PRAVASTATIN SODIUM

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

NITROFURANTOIN

Drug : NITROFURANTOIN

Dosage Form : SUSPENSION; ORAL

Application Number : 201355

Country : US

Patented : No

Strides Pharma Science

02

arrow
BIO Partnering at JPM
Not Confirmed

03

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

CLOBAZAM

Drug : CLOBAZAM

Dosage Form : SUSPENSION; ORAL

Application Number : 208819

Country : US

Patented : No

blank

04

arrow
BIO Partnering at JPM
Not Confirmed

05

arrow
BIO Partnering at JPM
Not Confirmed

06

arrow
BIO Partnering at JPM
Not Confirmed

07

arrow
BIO Partnering at JPM
Not Confirmed
PHARMOBEDIENT
Country
arrow
BIO Partnering at JPM
Not Confirmed

ERYTHROMYCIN ETHYLSUCCINATE

Drug : E.E.S. 400

Dosage Form : TABLET; ORAL

Application Number : 61905

Country : US

Patented : No

blank

08

PHARMOBEDIENT
arrow
BIO Partnering at JPM
Not Confirmed
PHARMOBEDIENT
Country
arrow
BIO Partnering at JPM
Not Confirmed

CLOBAZAM

Drug : CLOBAZAM

Dosage Form : SUSPENSION; ORAL

Application Number : 211259

Country : US

Patented : No

blank

09

SALERNO PHARMS
arrow
BIO Partnering at JPM
Not Confirmed
SALERNO PHARMS
Country
arrow
BIO Partnering at JPM
Not Confirmed

SIMVASTATIN

Drug : FLOLIPID

Dosage Form : SUSPENSION; ORAL

Application Number : 206679

Country : US

Patented : Yes

blank

10

PHARMOBEDIENT
arrow
BIO Partnering at JPM
Not Confirmed
PHARMOBEDIENT
Country
arrow
BIO Partnering at JPM
Not Confirmed

NYSTATIN

Drug : NYSTATIN

Dosage Form : SUSPENSION; ORAL

Application Number : 62512

Country : US

Patented : No

blank